R156-17b-621a

R156-17b-621a. Operating Standards - Pharmacist Administration of a Long-acting Injectable and Naloxone - Training

Last amended: 2025Length: 74 wordsOfficial source

Cite as Utah Admin. Code R156-17b-621a

In accordance with Subsections 58-17b-502(1)(i) and 58-17b-625(2): (1) Prior to engaging in the administration of a long-acting injectable drug pursuant to Section 58-17b-625, a pharmacist shall successfully complete: (a) current Basic Life Support (BLS) certification; and (b) a training program for administering long-acting injectables intramuscularly that is provided by an ACPE-accredited provider. (2) An individual who engages in the administration of long-acting injectable drugs intramuscularly shall maintain documentation that they obtained their required training.
R156-17b-621a: R156-17b-621a. Operating Standards - Pharmacist Administration of a Long-acting Injectable and Naloxone - Training | Justis AI